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Background
Macrophages are important targets for HIV-1 infection
and are involved in mucosal transmission of the virus.
Due to their ubiquitous distribution, macrophages play a
crucial role in virus spread and can become reservoirs
for HIV-1. In vivo, macrophages are exposed to a multi-
plicity of signals that can polarize them into a classically
activated M1 (IFN-g, LPS and/or TNF-a)o ri n t oa l t e r -
natively activated M2a (IL-4, IL-13) and M2c (IL-10,
glucocorticoids) phenotype. Previous studies have shown
that the susceptibility of macrophages to HIV-1 infec-
t i o ni sr e g u l a t e db yt y p eIi n t e r f e r o n s( I F N - a,I F N - b)
and by the cytokines IL-4 and IL-10, however the
mechanism underlying the latter has not been described
yet. In this study, the expression levels of HIV-1 restrict-
ing cellular factors in the different types of polarized
monocyte-derived macrophages (MDM) was analyzed
and their role in HIV-1 susceptibility was investigated.
Methodology
Monocytes were isolated from buffy coats from healthy
blood donors using density gradient separation followed
by plastic adherence. MDM with a M1, M2a and M2c
phenotype were obtained by culturing cells for 5 days in
t h ep r e s e n c eo fI F N - g,I F N - g/TNF-a,I L - 4a n dI L - 1 0 ,
respectively. Monocytes were also stimulated with type I
interferons and the colony-stimulating factors M-CSF and
GM-CSF. Polarization of MDM was confirmed by flow
cytometry. MDM susceptibility to infection was analyzed
with HIV-1/NL4-3BaL and a VSV-G-pseudotyped lucifer-
ase reporter virus. Expression of HIV-1 host restriction
factors was measured by RT-qPCR. Viral reverse tran-
scription products were detected, in order to identify at
which step inhibition of viral replication occurs.
Results
Macrophages differentiated in the presence of IFN-a,
IFN-b, IFN-g ±T N F - a (M1), IL-4 (M2a) or IL-10 (M2c),
differentially expressed characteristic membrane recep-
tors, such as CD14, CD16, CD64, CD80, CD162,
CD200R and CD206, confirming the activated/polarized
phenotype. Unpolarized and M-CSF/GM-CSF-stimulated
MDM were highly susceptible to infection, whereas IFN-
a, IFN-b, IFN-g±TNF-a, IL-4 or IL-10 treatment resulted
in a significant inhibition of virus replication. Infection of
these populations with a VSV-G-pseudotyped virus indi-
cated that HIV-1 replication was inhibited at a post-entry
level. Inhibition of viral replication occurs at an early step
in the replication cycle, in MDM stimulated with type I
interferons and in M1 and M2a MDM, whereas in M2c
macrophages, inhibition occurs after reverse trannscrip-
tion. Expression of HIV-1 restriction factors like APO-
BEC3G, Trim5a, CyPA, tetherin, Trim22 and recently
identified anti-HIV miRNAs was upregulated in MDM
treated with type I IFNs, and to a lesser extend in M1
polarized macrophages.
Conclusions
These results suggest that the host factors analyzed here
may contribute to inhibition of HIV-1 replication in
MDM by type I interferons. However, these factors are
not likely involved in HIV-1 inhibition in M1 or M2
macrophages. Additional studies are necessary to iden-
tify other host factors involved in the resistance of
polarized macrophages to HIV-1 infection.
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